No retraction, correction or concern found when last checked on Nov 5, 2026.

Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease

Huaqi Su, Yepy H. Rustam, Colin L. Masters and 6 more

Journal of Extracellular Vesicles · 2021 · CC BY

doi:10.1002/jev2.12089

Abstract

Lipid dyshomeostasis is associated with the most common form of dementia, Alzheimer's disease (AD). Substantial progress has been made in identifying positron emission tomography and cerebrospinal fluid biomarkers for AD, but they have limited use as front‐line diagnostic tools. Extracellular vesicles (EVs) are released by all cells and contain a subset of their parental cell composition, including lipids. EVs are released from the brain into the periphery, providing a potential source of tissue and disease specific lipid biomarkers. However, the EV lipidome of the central nervous system is currently unknown and the potential of brain‐derived EVs (BDEVs) to inform on lipid dyshomeostasis in AD remains unclear. The aim of this study was to reveal the lipid composition of BDEVs in human frontal cortex, and to determine whether BDEVs have an altered lipid profile in AD. Using semi‐quantitative mass spectrometry, we describe the BDEV lipidome, covering four lipid categories, 17 lipid classes and 692 lipid molecules. BDEVs were enriched in glycerophosphoserine (PS) lipids, a characteristic of small EVs. Here we further report that BDEVs are enriched in ether‐containing PS lipids, a finding that further establishes ether lipids as a feature of EVs. BDEVs in the AD frontal cortex offered improved detection of dysregulated lipids in AD over global lipid profiling of this brain region. AD BDEVs had significantly altered glycerophospholipid and sphingolipid levels, specifically increased plasmalogen glycerophosphoethanolamine and decreased polyunsaturated fatty acyl containing lipids, and altered amide‐linked acyl chain content in sphingomyelin and ceramide lipids relative to CTL. The most prominent alteration was a two‐fold decrease in lipid species containing anti‐inflammatory/pro‐resolving docosahexaenoic acid. The in‐depth lipidome analysis provided in this study highlights the advantage of EVs over more complex tissues for improved detection of dysregulated lipids that may serve as potential biomarkers in the periphery.

References 91

1.
Anand, S., Barnes, J. M., Young, S. A., Garcia, D. M., Tolley, H. D., Kauwe, J. S. K., & Graves, S. W. (2017 ). Discovery and confirmation of diagnostic serum lipid biomarkers for Alzheimer’s disease using direct infusion mass spectrometry. Journal of Alzheimer's Disease, 59, 277–290.
Not in our library10.3233/jad-170035
2.
Bandaru, V. V., Troncoso, J., Wheeler, D., Pletnikova, O., Wang, J., Conant, K., & Haughey, N. J. (2009 ). ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain. Neurobiology of Aging, 30, 591–599.
Not in our library10.1016/j.neurobiolaging.2007.07.024
3.
Barupal, D. K., Baillie, R., Fan, S., Saykin, A. J., Meikle, P. J., Arnold, M., Nho, K., Fiehn, O., Kaddurah‐DAOUK, R., & Alzheimer Disease Metabolomics, C. (2019 ). Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology. Alzheimers & Dementia, 11, 619–627.
Not in our library10.1016/j.dadm.2019.07.002
4.
Bazinet, R. P., & Laye, S. (2014 ). Polyunsaturated fatty acids and their metabolites in brain function and disease. Nature Reviews Neuroscience, 15, 771–785.
Not in our library10.1038/nrn3820
5.
Bennett, S. A., Valenzuela, N., Xu, H., Franko, B., Fai, S., & Figeys, D. (2013 ). Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease. Front Physiol, 4.
Not in our library10.3389/fphys.2013.00168
6.
Brouwers, J. F., Aalberts, M., Jansen, J. W., Van Niel, G., Wauben, M. H., Stout, T. A., Helms, J. B., & Stoorvogel, W. (2013 ). Distinct lipid compositions of two types of human prostasomes. Proteomics, 13, 1660–1666.
Not in our library10.1002/pmic.201200348
7.
Chan, R. B., Oliveira, T. G., Cortes, E. P., Honig, L. S., Duff, K. E., Small, S. A., Wenk, M. R., SHUI, G., & Di PAOLO, G. (2012 ). Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. Journal of Biological Chemistry, 287, 2678–2688.
Not in our library10.1074/jbc.m111.274142
8.
Chen, S., Datta‐Chaudhuri, A., Deme, P., Dickens, A., Dastgheyb, R., Bhargava, P., Bi, H., & Haughey, N. J. (2019 ). Lipidomic characterization of extracellular vesicles in human serum. Journal of Circulating Biomarkers, 8, 1849454419879848.
Not in our library10.1177/1849454419879848
9.
Cheng, L., Vella, L. J., Barnham, K. J., Mclean, C., Masters, C. L., & Hill, A. F. (2020 ). Small RNA fingerprinting of Alzheimer's disease frontal cortex extracellular vesicles and their comparison with peripheral extracellular vesicles. Journal of Extracellular Vesicles, 9, 1766822.
Not in our library10.1080/20013078.2020.1766822
10.
Cutler, R. G., Kelly, J., Storie, K., Pedersen, W. A., Tammara, A., Hatanpaa, K., Troncoso, J. C., & Mattson, M. P. (2004 ). Involvement of oxidative stress‐induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proceedings of the National Academy of Sciences, 101, 2070–2075.
Not in our library10.1073/pnas.0305799101
11.
Deleo, A. M., & Ikezu, T. (2018 ). Extracellular vesicle biology in Alzheimer's disease and related tauopathy. Journal of Neuroimmune Pharmacology, 13, 292–308.
Not in our library10.1007/s11481-017-9768-z
12.
Dorninger, F., Forss‐Petter, S., & Berger, J. (2017 ). From peroxisomal disorders to common neurodegenerative diseases ‐ the role of ether phospholipids in the nervous system. Febs Letters, 591, 2761–2788.
Not in our library10.1002/1873-3468.12788
13.
Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA · 2015
No notice
14.
Fahy, E., Subramaniam, S., Brown, H. A., Glass, C. K., Merrill, A. H., Murphy, R. C., Raetz, C. R. H., Russell, D. W., Seyama, Y., Shaw, W., Shimizu, T., Spener, F., Van Meer, G., Vannieuwenhze, M. S., White, S. H., Witztum, J. L., & Dennis, E. A. (2005 ). A comprehensive classification system for lipids. Journal of Lipid Research, 46, 839–862.
Not in our library10.1194/jlr.e400004-jlr200
15.
Fiala, M., Halder, R. C., Sagong, B., Ross, O., Sayre, J., Porter, V., & Bredesen, D. E. (2015 ). Omega‐3 supplementation increases amyloid‐beta phagocytosis and resolvin D1 in patients with minor cognitive impairment. Faseb Journal, 29, 2681–2689.
Not in our library10.1096/fj.14-264218
16.
Plasma 24-metabolite panel predicts preclinical transition to clinical stages of Alzheimer’s disease · 2015
Not checked
17.
Ginsberg, L., Rafique, S., Xuereb, J. H., Rapoport, S. I., & Gershfeld, N. L. (1995 ). Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Research, 698, 223–226.
Not in our library10.1016/0006-8993(95)00931-f
18.
Glaser, P. E., & Gross, R. W. (1994 ). Plasmenylethanolamine facilitates rapid membrane fusion: A stopped‐flow kinetic investigation correlating the propensity of a major plasma membrane constituent to adopt an HII phase with its ability to promote membrane. Biochemistry, 33, 5805–5812.
Not in our library10.1021/bi00185a019
19.
Gonzalez‐Dominguez, R., Garcia‐Barrera, T., & Gomez‐Ariza, J. L. (2014 ). Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease. Analytical and Bioanalytical Chemistry, 406, 7137–7148.
Not in our library10.1007/s00216-014-8102-3
20.
Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia · 2007
Not checked
21.
Grimm, M. O., Kuchenbecker, J., Rothhaar, T. L., Grosgen, S., Hundsdorfer, B., Burg, V. K., Friess, P., Muller, U., Grimm, H. S., Riemenschneider, M., & Hartmann, T. (2011 ). Plasmalogen synthesis is regulated via alkyl‐dihydroxyacetonephosphate‐synthase by amyloid precursor protein processing and is affected in Alzheimer's disease. Journal of Neurochemistry, 116, 916–925.
Not in our library10.1111/j.1471-4159.2010.07070.x
22.
Han, X., Fagan, A. M., Cheng, H., Morris, J. C., Xiong, C., & Holtzman, D. M. (2003 ). Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia. Annals of Neurology, 54, 115–119.
Not in our library10.1002/ana.10618
23.
Han, X., Holtzman, D. M., & Mckeel, D. M. (2001 ). Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: Molecular characterization using electrospray ionization mass spectrometry. Journal of Neurochemistry, 77, 1168–1180.
Not in our library10.1046/j.1471-4159.2001.00332.x
24.
Han, X., Holtzman, D. M., Mckeel, D. M., Kelley, J., & Morris, J. C. (2002 ). Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: Potential role in disease pathogenesis. Journal of Neurochemistry, 82, 809–818.
Not in our library10.1046/j.1471-4159.2002.00997.x
25.
Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics · 2011
No notice
26.
Haraszti, R. A., Didiot, M. C., Sapp, E., Leszyk, J., Shaffer, S. A., Rockwell, H. E., Gao, F., Narain, N. R., Difiglia, M., Kiebish, M. A., Aronin, N., & Khvorova, A. (2016 ). High‐resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. Journal of Extracellular Vesicles, 5, 32570.
Not in our library10.3402/jev.v5.32570
27.
Haughey, N. J., Bandaru, V. V. R., Bae, M., & Mattson, M. P. (2010 ). Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. Biochimica et Biophysica Acta (BBA) ‐ Molecular and Cell Biology of Lipids, 1801, 878–886.
Not in our library10.1016/j.bbalip.2010.05.003
28.
He, X., Huang, Y., Li, B., Gong, C.‐X., & Schuchman, E. H. (2010 ). Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiology of Aging, 31, 398–408.
Not in our library10.1016/j.neurobiolaging.2008.05.010
29.
Current knowledge on exosome biogenesis and release · 2017
No notice
30.
Hossain, M. S., Ifuku, M., Take, S., Kawamura, J., Miake, K., & Katafuchi, T. (2013 ). Plasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signaling. Plos One, 8, e83508.
Not in our library10.1371/journal.pone.0083508
31.
Igarashi, M., Ma, K., Gao, F., Kim, H. W., Rapoport, S. I., & Rao, J. S. (2011 ). Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. Journal of Alzheimers Disease, 24, 507–517.
Not in our library10.3233/jad-2011-101608
32.
Johnstone, R. M. A., Adam M., Hammond, J. R., Orr, L., & Turbide, C. (1987 ). Vesicle formation during reticulocyte maturation. The Journal of Biological Chemistry, 262, 9412–9420.
Not in our library
33.
Kanninen, K. M., Bister, N., Koistinaho, J., & Malm, T. (2016 ). Exosomes as new diagnostic tools in CNS diseases. Biochimica et Biophysica Acta (BBA) ‐ Molecular Basis of Disease, 1862, 403–410.
Not in our library10.1016/j.bbadis.2015.09.020
34.
Kastelowitz, N., & Yin, H. (2014 ). Exosomes and microvesicles: Identification and targeting by particle size and lipid chemical probes. Chembiochem, 15, 923–928.
Not in our library10.1002/cbic.201400043
35.
Koal, T., Klavins, K., Seppi, D., Kemmler, G., & Humpel, C. (2015 ). Sphingomyelin SM(d18:1/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid‐beta42, tau, and phospho‐tau‐181 levels. Journal of Alzheimers Disease, 44, 1193–1201.
Not in our library10.3233/jad-142319
36.
Phospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers · 2013
No notice
37.
Kosicek, M., Zetterberg, H., Andreasen, N., Peter‐Katalinic, J., & Hecimovic, S. (2012 ). Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease. Neuroscience Letters, 516, 302–305.
Not in our library10.1016/j.neulet.2012.04.019
38.
Laulagnier, K., Motta, C., Hamdi, S., Roy, S., Fauvelle, F., Pageaux, J., Kobayashi, T., Salles, J., Perret, B., Bonnerot, C., & Record, M. (2004 ). Mast cell‐ and dendritic cell‐derived exosomes display a specific lipid composition and an unusual membrane organization. The Biochemical Journal, 380, 161–171.
Not in our library10.1042/bj20031594
39.
Role of exosomal proteins in cancer diagnosis · 2017
No notice
40.
Llorente, A., Skotland, T., Sylvänne, T., Kauhanen, D., Róg, T., Orłowski, A., Vattulainen, I., Ekroos, K., & Sandvig, K. (2013 ). Molecular lipidomics of exosomes released by PC‐3 prostate cancer cells. Biochimica et Biophysica Acta (BBA) ‐ Molecular and Cell Biology of Lipids, 1831, 1302–1309.
Not in our library10.1016/j.bbalip.2013.04.011
41.
Lukiw, W. J., Cui, J. G., Marcheselli, V. L., Bodker, M., Botkjaer, A., Gotlinger, K., Serhan, C. N., & Bazan, N. G. (2005 ). A role for docosahexaenoic acid‐derived neuroprotectin D1 in neural cell survival and Alzheimer disease. Journal of Clinical Investigation, 115, 2774–2783.
Not in our library10.1172/jci25420
42.
Lydic, T. A., Townsend, S., Adda, C. G., Collins, C., Mathivanan, S., & Reid, G. E. (2015 ). Rapid and comprehensive ‘shotgun’ lipidome profiling of colorectal cancer cell derived exosomes. Methods (San Diego, Calif.), 87, 83–95.
Not in our library10.1016/j.ymeth.2015.04.014
43.
Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., Macarthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., & Federoff, H. J. (2014 ). Plasma phospholipids identify antecedent memory impairment in older adults. Nature Medicine, 20, 415–418.
Not in our library10.1038/nm.3466
44.
Subtypes of tumour cell-derived small extracellular vesicles having differently externalized phosphatidylserine · 2019
Not checked
45.
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., Lebleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., Reissfelder, C., Pilarsky, C., Fraga, M. F., Piwnica‐Worms, D., & Kalluri, R. (2015 ). Glypican‐1 identifies cancer exosomes and detects early pancreatic cancer. Nature, 523, 177–182.
Not in our library10.1038/nature14581
46.
Mielke, M. M., Bandaru, V. V. R., Haughey, N. J., Rabins, P. V., Lyketsos, C. G., & Carlson, M. C. (2010a ). Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiology of Aging, 31, 17–24.
Not in our library10.1016/j.neurobiolaging.2008.03.011
47.
Mielke, M. M., Haughey, N. J., Bandaru, V. V., Schech, S., Carrick, R., Carlson, M. C., Mori, S., Miller, M. I., Ceritoglu, C., Brown, T., Albert, M., & Lyketsos, C. G. (2010b ). Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimers & Dementia, 6, 378–385.
Not in our library10.1016/j.jalz.2010.03.014
48.
Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Weinberg, D. D., Darby, E., Zaidi, N., Pavlik, V., Doody, R. S., & Lyketsos, C. G. (2011 ). Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. Journal of Alzheimer's Disease, 27, 259–269.
Not in our library10.3233/jad-2011-110405
49.
Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Zetterberg, H., Blennow, K., Andreasson, U., Johnson, S. C., Gleason, C. E., Blazel, H. M., Puglielli, L., Sager, M. A., Asthana, S., & Carlsson, C. M. (2014 ). Cerebrospinal fluid sphingolipids, beta‐amyloid, and tau in adults at risk for Alzheimer's disease. Neurobiology of Aging, 35, 2486–2494.
Not in our library10.1016/j.neurobiolaging.2014.05.019
50.
Mielke, M. M., & Lyketsos, C. G. (2010 ). Alterations of the sphingolipid pathway in Alzheimer's disease: New biomarkers and treatment targets? Neuromolecular Medicine, 12, 331–340.
Not in our library10.1007/s12017-010-8121-y
51.
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003 ). Consumption of fish and n‐3 fatty acids and risk of incident Alzheimer Disease. Archives of Neurology, 60, 940–946.
Not in our library10.1001/archneur.60.7.940
52.
Pettegrew, J. W., Panchalingam, K., Hamilton, R. L., & Mcclure, R. J. (2001 ). Brain membrane phospholipid alterations in Alzheimer's disease. Neurochemical Research, 26, 771–782.
Not in our library10.1023/a:1011603916962
53.
Phuyal, S., Skotland, T., Hessvik, N. P., Simolin, H., Overbye, A., Brech, A., Parton, R. G., Ekroos, K., Sandvig, K., & Llorente, A. (2015 ). The ether lipid precursor hexadecylglycerol stimulates the release and changes the composition of exosomes derived from PC‐3 cells. Journal of Biological Chemistry, 290, 4225–4237.
Not in our library10.1074/jbc.m114.593962
54.
Rai, A., Greening, D. W., Chen, M., Xu, R., Ji, H., & Simpson, R. J. (2019 ). Exosomes derived from human primary and metastatic colorectal cancer cells contribute to functional heterogeneity of activated fibroblasts by reprogramming their proteome. Proteomics, 19(8).
Not in our library10.1002/pmic.201800148
55.
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006 ). Alzheimer's disease beta‐amyloid peptides are released in association with exosomes. Proceedings of the National Academy of Sciences, 103, 11172–11177.
Not in our library10.1073/pnas.0603838103
56.
Raposo, G., Nijman, H. W., Stoorvogel, W., Leijendekker, R., Harding, C. V. M., Cornelis, J. M., & Geuze, H. J. (1996 ). B lymphocytes secrete antigen‐presenting vesicles. Journal of Experimental Medicine, 183, 1161–1172.
Not in our library10.1084/jem.183.3.1161
57.
Record, M., Carayon, K., Poirot, M., & Silvente‐Poirot, S. (2014 ). Exosomes as new vesicular lipid transporters involved in cell‐cell communication and various pathophysiologies. Biochimica Et Biophysica Acta, 1841, 108–120.
Not in our library10.1016/j.bbalip.2013.10.004
58.
Record, M., Silvente‐Poirot, S., Poirot, M., & Wakelam, M. J. O. (2018 ). Extracellular vesicles: Lipids as key components of their biogenesis and functions. Journal of Lipid Research, 59, 1316–1324.
Not in our library10.1194/jlr.e086173
59.
Rustam, Y. H., & Reid, G. E. (2018 ). Analytical challenges and recent advances in mass spectrometry based lipidomics. Analytical Chemistry, 90, 374–397.
Not in our library10.1021/acs.analchem.7b04836
60.
Ryan, E., & Reid, G. E. (2016 ). Chemical Derivatization and ultrahigh resolution and accurate mass spectrometry strategies for “shotgun” lipidome analysis. Accounts of Chemical Research, 49, 1596–1604.
Not in our library10.1021/acs.accounts.6b00030
61.
The emerging role of exosomes in mental disorders · 2019
No notice
62.
Satoi, H., Tomimoto, H., Ohtani, R., Kitano, T., Kondo, T., Watanabe, M., Oka, N., Akiguchi, I., Furuya, S., Hirabayashi, Y., & Okazaki, T. (2005 ). Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis. Neuroscience, 130, 657–666.
Not in our library10.1016/j.neuroscience.2004.08.056
63.
Serhan, C. N., & Levy, B. D. (2018 ). Resolvins in inflammation: Emergence of the pro‐resolving superfamily of mediators. Journal of Clinical Investigation, 128, 2657–2669.
Not in our library10.1172/jci97943
64.
Serna, J., Garcia‐Seisdedos, D., Alcazar, A., Lasuncion, M. A., Busto, R., & Pastor, O. (2015 ). Quantitative lipidomic analysis of plasma and plasma lipoproteins using MALDI‐TOF mass spectrometry. Chemistry and Physics of Lipids, 189, 7–18.
Not in our library10.1016/j.chemphyslip.2015.05.005
65.
Sharma, R., Huang, X., Brekken, R. A., & Schroit, A. J. (2017 ). Detection of phosphatidylserine‐positive exosomes for the diagnosis of early‐stage malignancies. British Journal of Cancer, 117, 545–552.
Not in our library10.1038/bjc.2017.183
66.
Sharples, R. A., Vella, L. J., Nisbet, R. M., Naylor, R., Perez, K., Barnham, K. J., Masters, C. L., & Hill, A. F. (2008 ). Inhibition of gamma‐secretase causes increased secretion of amyloid precursor protein C‐terminal fragments in association with exosomes. Faseb Journal, 22, 1469–1478.
Not in our library10.1096/fj.07-9357com
67.
Plasmalogen enrichment in exosomes secreted by a nematode parasite versus those derived from its mouse host: implications for exosome stability and biology · 2016
Not checked
68.
Simons, M., & Raposo, G. (2009 ). Exosomes ‐ vesicular carriers for intercellular communication. Current Opinion in Cell Biology, 21, 575–581.
Not in our library10.1016/j.ceb.2009.03.007
69.
Skotland, T., Ekroos, K., Kauhanen, D., Simolin, H., Seierstad, T., Berge, V., Sandvig, K., & Llorente, A. (2017a ). Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers. European Journal of Cancer, 70, 122–132.
Not in our library10.1016/j.ejca.2016.10.011
70.
Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology · 2019
No notice
71.
Skotland, T., Sagini, K., Sandvig, K., & Llorente, A. (2020 ). An emerging focus on lipids in extracellular vesicles. Advanced Drug Delivery Reviews, 159, 308–321.
Not in our library10.1016/j.addr.2020.03.002
72.
Skotland, T., Sandvig, K., & Llorente, A. (2017b ). Lipids in exosomes: Current knowledge and the way forward. Progress in Lipid Research, 66, 30–41.
Not in our library10.1016/j.plipres.2017.03.001
73.
Skoumalová, A., Ivica, J., Šantorová, P., Topinková, E., & Wilhelm, J. (2011 ). The lipid peroxidation products as possible markers of Alzheimer's disease in blood. Experimental Gerontology, 46, 38–42.
Not in our library10.1016/j.exger.2010.09.015
74.
Plasmalogens and Alzheimer’s disease: a review · 2019
No notice
75.
Sun, Y., Saito, K., & Saito, Y. (2019 ). Lipid profile characterization and lipoprotein comparison of extracellular vesicles from human plasma and serum. Metabolites, 9(11).
Not in our library10.3390/metabo9110259
76.
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., Ayre, D. C., Bach, J. M., Bachurski, D., Baharvand, H., Balaj, L., Baldacchino, S., Bauer, N. N., Baxter, A. A., Bebawy, M. … Zuba‐Surma, E. K. (2018 ). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles, 7, 1535750.
Not in our library10.1080/20013078.2018.1535750
77.
Thompson, A. G., Gray, E., Heman‐Ackah, S. M., Mager, I., Talbot, K., Andaloussi, S. E., Wood, M. J., & Turner, M. R. (2016 ). Extracellular vesicles in neurodegenerative disease ‐ pathogenesis to biomarkers. Nature Reviews Neurology, 12, 346–357.
Not in our library10.1038/nrneurol.2016.68
78.
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., & Simons, M. (2008 ). Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science, 319, 1244–1247.
Not in our library10.1126/science.1153124
79.
Tully, A. M., Roche, H. M., Doyle, R., Fallon, C., Bruce, I., Lawlor, B., Coakley, D., & Gibney, M. J. (2003 ). Low serum cholesteryl ester‐docosahexaenoic acid levels in Alzheimer's disease: A case‐control study. British Journal of Nutrition, 89, 483–489.
Not in our library10.1079/bjn2002804
80.
Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer’s and Parkinson’s Disease · 2016
No notice
81.
A rigorous method to enrich for exosomes from brain tissue · 2017
Not checked
82.
Vingtdeux, V., Sergeant, N., & Buée, L. (2012 ). Potential contribution of exosomes to the prion‐like propagation of lesions in Alzheimer's disease. Frontiers in Physiology, 3.
Not in our library10.3389/fphys.2012.00229
83.
Wallner, S., & Schmitz, G. (2011 ). Plasmalogens the neglected regulatory and scavenging lipid species. Chemistry and Physics of Lipids, 164, 573–589.
Not in our library10.1016/j.chemphyslip.2011.06.008
84.
Wang, H., & Eckel, R. H. (2014 ). What are lipoproteins doing in the brain? Trends in Endocrinology & Metabolism, 25, 8–14.
Not in our library10.1016/j.tem.2013.10.003
85.
Wang, M., Wang, C., & Han, X. (2017 ). Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry‐What, how and why? Mass Spectrometry Reviews, 36, 693–714.
Not in our library10.1002/mas.21492
86.
Wei, X., Liu, C., Wang, H., Wang, L., Xiao, F., Guo, Z., & Zhang, H. (2016 ). Surface phosphatidylserine Is responsible for the internalization on microvesicles derived from hypoxia‐induced human bone marrow mesenchymal stem cells into human endothelial cells. Plos One, 11, e0147360.
Not in our library10.1371/journal.pone.0147360
87.
Whiley, L., Sen, A., Heaton, J., Proitsi, P., García‐Gómez, D., Leung, R., Smith, N., Thambisetty, M., Kloszewska, I., Mecocci, P., Soininen, H., Tsolaki, M., Vellas, B., Lovestone, S., & Legido‐Quigley, C. (2014 ). Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease. Neurobiology of Aging, 35, 271–278.
Not in our library10.1016/j.neurobiolaging.2013.08.001
88.
Whittington, R. A., Planel, E., & Terrando, N. (2017 ). Impaired resolution of inflammation in Alzheimer's disease: A review. Frontiers in immunology, 8.
Not in our library10.3389/fimmu.2017.01464
89.
Wong, M. W., Braidy, N., Poljak, A., Pickford, R., Thambisetty, M., & Sachdev, P. S. (2017 ). Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers. Alzheimers & Dementia, 13, 810–827.
Not in our library10.1016/j.jalz.2017.01.008
90.
Wood, P. L. (2012 ). Lipidomics of Alzheimer's disease: Current status. Alzheimer's Research & Therapy, 4(1).
Not in our library10.1186/alzrt103
91.
Wood, P. L., Mankidy, R., Ritchie, S., Heath, D., Wood, J. A., Flax, J., & Goodenowe, D. B. (2010 ). Circulating plasmalogen levels and Alzheimer Disease Assessment Scale–Cognitive scores in Alzheimer patients. Journal of Psychiatry and Neuroscience, 35, 59–62.
Not in our library10.1503/jpn.090059

Cited by papers we hold 2

Cell–cell communication: new insights and clinical implications · 2024
No notice
The lipid composition of extracellular vesicles: applications in diagnostics and therapeutic delivery · 2023
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.